ArcherDX partners with Illumina to develop in-vitro diagnostic tests

ArcherDX partners with Illumina to develop in-vitro diagnostic tests

BOULDER -- ArcherDX, Inc. , a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive... Read More

Tuesday December 3, 2019 0 comments Tags: Boulder, ArcherDx, Illumina, Jason Myers, Phil Febbo